Skip to content

Barrett*s Esophagus and Adenocarcinoma STudy (EAST); The inflammatory background

Barrett*s Esophagus and Adenocarcinoma STudy (EAST); The inflammatory background - Barrett*s Esophagus and Adenocarcinoma STudy (EAST)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON37304
Enrollment
304
Registered
2009-08-11
Start date
2009-09-30
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Barrett's esophagus

Interventions

None listed

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Upper gastrointestinal tract endoscopy for the indications gastro-esophageal reflux disease (GERD), aspecific complaints, BE or BE associated EAC. 2. Patients older then 18 years old. 3. Written informed consent.

Exclusion criteria

Exclusion criteria: 1. Pregnancy 2. History of esophagectomy or gastrectomy. 3. Reflux symptoms in the absence of endoscopic RE. 4. Esophageal squamous cell carcinoma. 5. Cardiacarcinoma or EAC not associated with BE. 6. Unable to fill out the questionnaire.;* reflux symptoms in the absence of endoscopic RE * esophageal squamous carcinoma * cardiacarcinoma or EAC not associated with BE

Design outcomes

Primary

MeasureTime frame
Differences in the composition of immune cells and the expression of immunological factors between normal squamous epithelium, RE, BE and EAC.

Secondary

MeasureTime frame
Not applicable.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)